Speaker

PhD in Microelectronics Engineering, University of Texas at Austin; MS from Institute of Theoretical Physics, Chinese Academy of Sciences; BS from Peking University.

With over 30 years of experience in Silicon Valley tech companies (including Intel), he specializes in AI, deep learning, large language models, NLP, and computer vision. He served as Conference Chair for IEEE ICRAE and other international conferences, holds 62 patents (China/US/EU), and has published 75 SCI papers.

Currently, he is a Professor and PhD Advisor at the Beijing Institute of Nanoenergy and Nanosystems, CAS, leading a digital TCM platform initiative. He also holds leadership roles in the World Federation of Chinese Medicine Societies and the Chinese Society of Biomedical Engineering.

Chen Ruixiang, Professor at ​Beijing University of Chinese Medicine, former Director of the Department of Mathematics and Physics at the College of Chinese Materia Medica, and member of the Teaching Guidance Committee. Vice Chairman of the ​Beijing Research Society of Traditional Chinese Medicine Orthopedics and Traumatology. Awarded the ​Outstanding Contribution Award​ by the UNESCO Association in 2014. Key academic achievements: established a modern logical system for Chinese characters; his monograph was selected as an official gift book for the ​2008 Beijing Olympics Cultural Exchange Activities​ and licensed merchandise for the ​2010 Shanghai World Expo; developed an axiomatic system for modeling fundamental principles of Traditional Chinese Medicine theory and diagnosis/treatment algorithm models; constructed the ​11-tier Life Philosophy System of Chinese Culture; served as first editor or co-editor for over 10 nationally planned textbooks; led or participated in more than 10 scientific research projects.

Zhang Dong, Director Physician and Professor of Cardiology at Xiyuan Hospital, China Academy of Chinese Medical Sciences, holds a Doctor of Medicine degree. He is the fourth cohort inheritor of the National Master of Traditional Chinese Medicine Apprenticeship Program and a second cohort Inheritance Postdoctoral Fellow under the National Administration of Traditional Chinese Medicine. Mentored by Professor Weng Weiliang (National Master of Traditional Chinese Medicine) and Academician Wang Yongyan. Graduated from Beijing University of Chinese Medicine. Engaged in clinical practice, scientific research, and teaching for over 30 years at the Department of Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences. Renowned Young and Middle-aged Traditional Chinese Medicine Expert of the China Academy of Chinese Medical Sciences.

Member, Science and Technology Working Committee, World Federation of Acupuncture-Moxibustion Societies (WFAS)
Member, Constitution Branch, China Association of Chinese Medicine
Standing Committee Member & Deputy Secretary-General, Qihuang Needle Therapy Committee, China Acupuncture-Moxibustion Association
Standing Committee Member, Andrology Branch, Guangdong Association of Chinese Medicine
Vice-Chairman, Allergy Branch, Guangdong Health Science Popularization Promotion Association
Council Member, Guangdong Rehabilitation Medicine Association
Guangzhou Health Science Popularization Expert
Peer Reviewer, Journal of Sun Yat-sen University (Medical Sciences)
Peer Reviewer, The New Medicine
First Deputy Editor-in-Chief, Qihuang Needle Therapy, People’s Medical Publishing House
First Deputy Editor-in-Chief, Selected Clinical Case Studies on Qihuang Needle Therapy, China Science & Technology Press
Author of more than ten peer-reviewed publications

Professor Zhang Mianzhi, Doctor of Nephrology, Postdoctoral Fellow in Traditional Chinese Medicine, Chief Physician, Second-Class Professor, is a doctoral supervisor and postdoctoral co-supervisor at three universities including Beijing University of Chinese Medicine and Tianjin Medical University. He is an expert enjoying special government allowances from the State Council, one of the first “Famous Doctors in Tianjin”, a “Famous Traditional Chinese Medicine Doctor in Tianjin”, and a leading talent of Beijing’s “Yiqilin” program.

He serves as a member of the National Committee of the Chinese People’s Political Consultative Conference (CPPCC) and a member of the Education, Science, Health and Sports Committee of the CPPCC National Committee. He is also Vice President of the China Association for the Promotion of Chinese Medicine Research, Director of the Branch of Tonifying Kidney and Activating Blood Circulation of the China Association of Chinese Medicine, and Deputy Director of the Nephrology Branch of the China Association of Chinese Medicine.

Currently, he holds the positions of President of Tianjin Integrated Traditional Chinese and Western Medicine Hospital, Director of the Institute of Traditional Chinese Medicine Nephrology of Tianjin Academy of Traditional Chinese Medicine, Academic Leader of the National Regional TCM (Specialty) Diagnosis and Treatment Center, Academic Leader of Key Specialties of the National Health Commission and the State Administration of Traditional Chinese Medicine, Director of Tianjin Integrated Traditional Chinese and Western Medicine Nephrology Consultation Center, Visiting Professor at the School of Chinese Medicine of The Chinese University of Hong Kong, Distinguished Professor at the First Affiliated Hospital of Zhengzhou University, Leader of the Introduced High-Level TCM Medical Team in Shenzhen, and Leader of Zhang Mianzhi’s Beijing Municipal Famous TCM Doctor Team.

Prof. Cong Yan is from School of Life Sciences, Beijing University of Chinese Medicine. He is a member of the Academic Committee and serves as the director of the Wei Gao Research Institute and the Center for Traditional Chinese Medicine Inheritance and Digitalization. He is an editorial board member and reviewer for journals such as TMR Modern Traditional Chinese Medicine Journal and Practical Clinical Medicine Journal, as well as serving as an executive council member of the World Federation of Chinese Medicine Societies’ Committee on Evaluation and Promotion of Appropriate Techniques in Traditional Chinese Medicine. Currently, Prof. Yan’s group is focusing on the construction of mathematical and physical system of the traditional Chinese medicine, as well as the development of intelligent traditional Chinese medicine diagnosis and treatment technology. At the same time, Prof. Yan undertakes the school-enterprise combination and achievement transformation work in the field of traditional Chinese medicine, focusing on the fields of smart Chinese medicine diagnosis and treatment equipment, traditional Chinese medicine digital therapy, digital Chinese medicine services, etc.. as well as the industrialization of new clinical technologies, new products of traditional Chinese medicine.

Graeme Spencer is HDR’s Education & Science Principal and a recognised leader in designing future-focused campuses and biomedical precincts across Australia. With over 25 years of cross-disciplinary experience, he brings bold ideas and deep expertise to projects that integrate education, health, science, and data infrastructure.

Graeme has led the design of high-impact projects including the Sydney Biomedical Accelerator, Western Sydney University’s Bankstown City Campus, and CSIRO’s high-containment research facilities. He’s a champion of “connectivity by design,” creating open, flexible labs and collaborative precincts that accelerate discovery from bench to bedside.

He also spearheads HDR’s data-driven design tools, helping institutions visualise and optimise campus assets in real time. Graeme continues to shape the future of education and research through design that is human-centred, rigorous, and strategically impactful.

David Boehm, Founder of Miskawaan Health Group, was amazed by the transformative effects after personally experiencing Chlorogenic Acid extension in deep sleep duration, improvement in morning vitality and significant enhancement in immunoglobulin levels. This inspired him to introduce this revolutionary compound to Asian markets. Driven by a profound passion for functional medicine, David champions a philosophy that heals not just individuals, but also contributes to global wellness. As he often says, “If an herb has proven medicinal value or the potential to benefit human health—no matter where in the world it originates—I will undoubtedly study it thoroughly and explore its practical applications. This is not just a professional pursuit, but a personal passion rooted in my deep respect for traditional medicine and natural healing.  His commitment to holistic health and a vision where transformative care reaches communities worldwide and together with Chairman Zhang joined forces to develop and market this product under the brand name OROJIN.

Zhang Jie, Founder & Chairman of Jiu Zhang Biotech (Chengdu) and CEO, is the original developer of the globally pioneering new drugs “Chlorogenic Acid Active Pharmaceutical Ingredient (API)” and “Chlorogenic Acid for Injection.” He holds 53 Chinese invention patents and 29 international invention patents related to chlorogenic acid. In 2016, Chairman Zhang Jie was interviewed by Nature magazine, with the feature published in the December 22, 2016, issue. His key research findings have been documented in 5 international SCI-indexed papers.
He led the development of the National Eighth Five-Year Plan Key Scientific and Technological Project “FZ-1 Energy-Saving Friction Reducer and Efficiency Enhancer,” which received the 1992 ​Second Prize of Sichuan Provincial Science and Technology Progress Award​ and was included in the ​National Key New Product Program. He also organized the 2016 ​National Thirteenth Five-Year Plan Major New Drug Discovery and Development Program​ for the “Phase I/II Clinical Study of First-in-Class Category 1 New Drug Chlorogenic Acid for Injection,” which passed national review in 2020.

John is a scientific leader with 25 years of experience spanning research, biotech/medtech R&D and operations, incl. clinical settings. As Chief Scientific Officer at MiskawaanHealth Group, he oversees the clinical development and integration of advanced therapeutic products—including cell therapies, regenerative technologies, and natural medicines—into functional and integrative healthcare for cancer, chronic diseases, and healthy ageing. John’s expertise covers oncology, medical devices, stem cells and targeted delivery systems for therapeutics and nutraceuticals. He leads multidisciplinary teams in the development of next-generation therapies, managing multiple clinical trials, registration of new products, procurement of medicines, and drives the international expansion of longevity clinics. His core scientific skills include molecular and cellular biology, cell encapsulation, virology, microbiome and microbiology, with a strong focus on translating research into innovative medical solutions.